- ALL
Prof. TAKEBE Takanori selected for “TIME100 Most Influential People in Health 2026”
On February 11, 2026 (U.S. Eastern Time), TIME magazine announced its “TIME100 Most Influential People in Health 2026,” and Professor TAKEBE Takanori, Deputy Director of the Premium Research Institute for Human Metaverse Medicine (WPI-PRIMe), the University of Osaka (Professor, Genome Biology [Stem Cell and Organoid Medicine], Graduate School of Medicine), was selected for the list.
The “TIME100 Most Influential People in Health” honors leaders, innovators, and pioneers who have transformed—or are transforming—the future of global health and medicine for the better. Professor Takebe and his research group were recognized for their series of pioneering research achievements addressing end-stage organ failure. In particular, their Phase I first-in-human clinical trial report, published in Med in October 2025, received significant acclaim. The study verified the safety of an enteral ventilation method—described as “breathing through the digestive tract.”
The success of this trial represents a major breakthrough in advancing a medical concept—previously limited to the animal testing stage—toward clinical application in humans. This achievement is expected to contribute to the development of a novel therapeutic approach—enteral ventilation—that may help save patients’ lives, including those suffering from conditions beyond respiratory diseases.